Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections
Authors:
Open Access
- 1 June 2016
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 54 (6) , 1638-1640
Abstract
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMI). In this analysis of 39 NAIMI episodes, minimal inhibitory concentration (MIC) of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC≤0.5 μg/ml was significantly associated with better 6 week outcomes.Keywords
This publication has 15 references indexed in Scilit:
- Improvement in the outcome of invasive fusariosis in the last decadeClinical Microbiology and Infection, 2014
- Our 2014 approach to mucormycosisMycoses, 2014
- Epidemiology of Invasive Mold Infections in Lung Transplant RecipientsAmerican Journal of Transplantation, 2014
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersClinical Microbiology and Infection, 2014
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013Clinical Microbiology and Infection, 2014
- InvasiveScopulariopsis brevicaulisinfection in an immunocompromised patient and review of prior cases caused byScopulariopsisandMicroascusspeciesMedical Mycology, 2012
- A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)Clinical Infectious Diseases, 2012
- International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with VoriconazoleAntimicrobial Agents and Chemotherapy, 2010
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) DatabaseClinical Infectious Diseases, 2010
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008